A Paraneoplastic Syndrome Characterized by Extremity Swelling with Associated Inflammatory Infiltrate Heralds Aggressive Transformation of Myelodysplastic Syndromes/Myeloproliferat...

por Mangan, James K., Luger, Selina M.
Publicado 2012

Dose intensity for induction in acute myeloid leukemia: what, when, and for whom?

por McCurdy, Shannon R., Luger, Selina M.
Publicado 2021

A phase II study of sorafenib (BAY 43–9006) in recurrent diffuse large B cell lymphoma: an eastern cooperative oncology group study (E1404)

por Greenwald, Daniel R, Li, Hailun, Luger, Selina M, Go, Ronald S, King, David, Patel, Taral, Gascoyne, Randy D, Kolesar, Jill, Kahl, Brad S, Horning, Sandra
Publicado 2013

A Modified Integrated Genetic Model for Risk Prediction in Younger Patients with Acute Myeloid Leukemia

por Sloan, Caroline E., Luskin, Marlise R., Boccuti, Anne M., Sehgal, Alison R., Zhao, Jianhua, Daber, Robert D., Morrissette, Jennifer J. D., Luger, Selina M., Bagg, Adam, Gimotty, Phyllis A., Carroll, Martin
Publicado 2016

Inflammatory Cytokine Inhibition with Combination Daclizumab and Infliximab for Steroid Refractory Acute Graft-Versus-Host Disease

por Rager, Alison, Frey, Noelle, Goldstein, Steven C, Reshef, Ran, Hexner, Elizabeth O, Loren, Alison, Luger, Selina M, Perl, Alexander, Tsai, Donald, Davis, Jennifer, Vozniak, Michael, Smith, Jacqueline, Stadtmauer, Edward A, Porter, David L
Publicado 2010

CNS involvement in AML at diagnosis is rare and does not affect response or survival: data from 11 ECOG-ACRIN trials

por Ganzel, Chezi, Lee, Ju-Whei, Fernandez, Hugo F., Paietta, Elisabeth M., Luger, Selina M., Lazarus, Hillard M., Cripe, Larry D., Douer, Dan, Wiernik, Peter H., Rowe, Jacob M., Tallman, Martin S., Litzow, Mark R.
Publicado 2021

Dynamic evolution of clonal epialleles revealed by methclone

por Li, Sheng, Garrett-Bakelman, Francine, Perl, Alexander E, Luger, Selina M, Zhang, Chao, To, Bik L, Lewis, Ian D, Brown, Anna L, D’Andrea, Richard J, Ross, M Elizabeth, Levine, Ross, Carroll, Martin, Melnick, Ari, Mason, Christopher E
Publicado 2014

Disparities in trial enrollment and outcomes of Hispanic adolescent and young adult acute lymphoblastic leukemia

por Muffly, Lori, Yin, Jun, Jacobson, Sawyer, Wall, Anna, Quiroz, Elisa, Advani, Anjali S., Luger, Selina M., Tallman, Martin S., Litzow, Mark R., Foster, Matthew C., Erba, Harry P., Appelbaum, Frederick R., Larson, Richard A., Keegan, Theresa H.M., Stock, Wendy
Publicado 2022

ETV6 mutations in early immature human T cell leukemias

por Van Vlierberghe, Pieter, Ambesi-Impiombato, Alberto, Perez-Garcia, Arianne, Haydu, J. Erika, Rigo, Isaura, Hadler, Michael, Tosello, Valeria, Della Gatta, Giusy, Paietta, Elisabeth, Racevskis, Janis, Wiernik, Peter H., Luger, Selina M., Rowe, Jacob M., Rue, Montserrat, Ferrando, Adolfo A.
Publicado 2011

Incidence and Predictors of Sars-Cov-2 Antibody Responses Following COVID-19 Vaccination in Allogeneic Stem Cell Transplant Recipients

por Minehart, Janna C., Catania, Christopher, Perry, Linda, Martin, Mary Ellen, Smith, Jacqueline, McCurdy, Shannon R., Pratz, Keith W., Luger, Selina M., Timlin, Colleen, Perl, Alexander E., Schuster, Mindy, Porter, David L, Loren, Alison W., Hexner, Elizabeth O., Frey, Noelle V
Publicado 2021

The impact of early PEG-asparaginase discontinuation in young adults with ALL: a post hoc analysis of the CALGB 10403 study

por Aldoss, Ibrahim, Yin, Jun, Wall, Anna, Mrózek, Krzysztof, Liedtke, Michaela, Claxton, David F., Foster, Matthew C., Appelbaum, Frederick R., Erba, Harry P., Litzow, Mark R., Tallman, Martin S., Stone, Richard M., Larson, Richard A., Advani, Anjali S., Stock, Wendy, Luger, Selina M.
Publicado 2022

High Incidence of Philadelphia Chromosome-Like Acute Lymphoblastic Leukemia (Ph-like ALL) in Older Adults with B-ALL

por Tasian, Sarah K, Hurtz, Christian, Wertheim, Gerald B, Bailey, Nathanael G, Lim, Megan S, Harvey, Richard C, Chen, I-Ming, Willman, Cheryl L, Astles, Rachel, Zebrowski, Alexis, Reshmi, Shalini C, Li, Marilyn M, Frey, Noelle V, Luger, Selina M, Carroll, Martin, Perl, Alexander E
Publicado 2016

At three years, patients with acute lymphoblastic leukaemia are still at risk for relapse. Results of the international MRC UKALLXII/ECOG E2993 trial

por Ganzel, Chezi, Wang, Xin V., Rowe, Jacob M., Richards, Susan M., Buck, Georgina, Marks, David I., Litzow, Mark R., Paietta, Elisabeth M., Foroni, Letizia, Luger, Selina M., Willman, Cheryl L., Mullighan, Charles G., Roberts, Kathryn G., Wiernik, Peter H., Douer, Dan, Lazarus, Hillard M., Tallman, Martin S., Goldstone, Anthony H.
Publicado 2020

SIMILAR OUTCOMES USING MYELOABLATIVE VERSUS REDUCED INTENSITY ALLOGENEIC TRANSPLANT PREPARATIVE REGIMENS FOR AML OR MDS

por Luger, Selina M., Ringdén, Olle, Zhang, Mei-Jie, Pérez, Waleska S., Bishop, Michael R., Bornhauser, Martin, Bredeson, Christopher N., Cairo, Mitchell S., Copelan, Edward A., Gale, Robert Peter, Giralt, Sergio A., Gulbas, Zafer, Gupta, Vikas, Hale, Gregory A., Lazarus, Hillard M., Lewis, Victor Anthony, Lill, Michael C., McCarthy, Philip L., Weisdorf, Daniel J., Pulsipher, Michael A.
Publicado 2011

Real-world effectiveness of CPX-351 vs venetoclax and azacitidine in acute myeloid leukemia

por Matthews, Andrew H., Perl, Alexander E., Luger, Selina M., Loren, Alison W., Gill, Saar I., Porter, David L., Babushok, Daria V., Maillard, Ivan P., Carroll, Martin P., Frey, Noelle V., Hexner, Elizabeth O., Martin, Mary Ellen, McCurdy, Shannon R., Stadtmauer, Edward A., Paralkar, Vikram R., Bruno, Ximena Jordan, Hwang, Wei-Ting, Margolis, David, Pratz , Keith W.
Publicado 2022

The New NCI Precision Medicine Trials

por Harris, Lyndsay N., Blanke, Charles D., Erba, Harry P., Ford, James M., Gray, Robert J., LeBlanc, Michael L., Hu-Lieskovan, Siwen, Litzow, Mark R., Luger, Selina M., Meric-Bernstam, Funda, O'Dwyer, Peter J., Othus, Megan K.D., Politi, Katerina, Shepherd, Lois E., Allegra, Carmen J., Chen, Helen X., Ivy, S. Percy, Korde, Larissa A., Little, Richard F., McShane, Lisa M., Moscow, Jeffrey A., Patton, David R., Thurin, Magdalena, Yee, Laura M., Doroshow, James H.
Publicado 2023

Genomic analyses identify recurrent MEF2D fusions in acute lymphoblastic leukaemia

por Gu, Zhaohui, Churchman, Michelle, Roberts, Kathryn, Li, Yongjin, Liu, Yu, Harvey, Richard C., McCastlain, Kelly, Reshmi, Shalini C., Payne-Turner, Debbie, Iacobucci, Ilaria, Shao, Ying, Chen, I-Ming, Valentine, Marcus, Pei, Deqing, Mungall, Karen L., Mungall, Andrew J., Ma, Yussanne, Moore, Richard, Marra, Marco, Stonerock, Eileen, Gastier-Foster, Julie M., Devidas, Meenakshi, Dai, Yunfeng, Wood, Brent, Borowitz, Michael, Larsen, Eric E., Maloney, Kelly, Mattano Jr, Leonard A., Angiolillo, Anne, Salzer, Wanda L., Burke, Michael J., Gianni, Francesca, Spinelli, Orietta, Radich, Jerald P., Minden, Mark D., Moorman, Anthony V., Patel, Bella, Fielding, Adele K., Rowe, Jacob M., Luger, Selina M., Bhatia, Ravi, Aldoss, Ibrahim, Forman, Stephen J., Kohlschmidt, Jessica, Mrózek, Krzysztof, Marcucci, Guido, Bloomfield, Clara D., Stock, Wendy, Kornblau, Steven, Kantarjian, Hagop M., Konopleva, Marina, Paietta, Elisabeth, Willman, Cheryl L., L. Loh, Mignon, P. Hunger, Stephen, Mullighan, Charles G.
Publicado 2016